Plain-English translation of NCT07213804 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Neoplasms research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a large clinical trial testing a new medication called for people with certain types of ovarian, fallopian tube, and peritoneal cancer. The trial has three separate parts, each designed for people at different stages of their cancer journey — some whose cancer came back quickly after chemotherapy, and others whose cancer stayed away longer. Researchers want to find out if this new treatment works better than the standard options doctors use today.
Many people with ovarian cancer eventually develop resistance to platinum-based chemotherapy, meaning their cancer stops responding to these standard drugs. This trial exists to test whether this new medication could offer a better option for people whose cancer has returned or isn't responding well to current treatments.
You likely qualify if…
You likely don't qualify if…
Participants receive intravenous infusions of either the new medication or standard treatment, depending on which group they are assigned to. Some participants also receive a medication called along with their treatment. Your doctor will monitor you regularly with scans and blood tests to see how you're responding, and your time in the study will depend on how well the treatment works for you and how your body tolerates it.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States